Need help with a claim involving MedDen Financial Services LLP

If you’re worried about losses from a transaction involving MedDen Financial Services LLP and are considering compensation, our experts can help. We’ll review your case thoroughly to determine what happened, who’s responsible, and how much you could potentially recover.

No win, no fee

If you don’t get paid, then you pay nothing. If you get paid, we take a pre-agreed percentage based on how much money you receive for your peace of mind.

MEDDEN FIANANCIAL SERVICES LLP

Trading Styles:

Current Names Status Date
MedDen Financial Services LLP Registered 22 Jan 2008
MedDen Independent Financial Advisers Trading 01 Oct 2007
Previous Names Status Start Date End Date
A World Overseas Wealth Management Trading 11 Jun 2010 11 Oct 2011
Dental & Medical Independent Financial Advisers Trading 08 Mar 2010 11 Oct 2011

 

Why can you claim for compensation or redress against MedDen Financial Services LLP

The Financial Services Compensation Scheme has declared MedDen Financial Services LLP (FRN: 454020) as failed as of 27/05/2021.

The firm no longer exists, so you may be able to make a claim against it.

 

Background

Companies House show the Company was incorporated on 30/08/2007.

According to the FCA Register the company has not been authorised since 16/08/2024.

This company is associated with claims over a Bermudian investment bond.

Many of the claims against it relate to unsuitable advice to transfer into the Centaur Bond, an investment listed on the Bermuda Stock Exchange.

 

Who was involved?

The following is a list of individuals who are currently or were previously involved in regulated activities at MedDen Financial Services LLP.

Previous
Name
Martin Paul Cooke
Craig Buchan
John Francis Joseph Timoney
Richard James Kirk Brown
Jonathan Lecomber
Eamonn Gallagher
Katherine Lindsay Wainwright
Martin Winter
Christopher Paul Johnson
Joanne Cargill
Jason Fisher
Pamela Mary Ellen McGowan
Robert Clint McQuire
Mohammed Yusuf Adrian Bashforth
Richard John Baxter
Mark Stephen Richards
James Richard McVay
Megan Ann Lough
Alan Gibson
Thomas Edward Lilley
Deborah Janet Tiffany
Paul Hainsworth

 

How can we help?

We have helped thousands of customers on a no-win no-fee basis get the compensation and justice they deserve when making claim against regulated companies like MedDen Financial Services LLP

 

How does it work?

The first step is a free no-obligation consultation, you can learn more about services on our making a claim page.

Once we have assessed your claim, if we believe you are due compensation then we will help you build the best possible complaint by launching a full investigation, gathering evidenced from all the relevant parties to package your claim and submit to the Financial Services Compensation Scheme. We will argue your case to ensure you receive the maximum amount of compensation available to you.

 

Seek Claim Advice Today

We offer an expert pension consulting service. One of our experts will be able to talk through your options and tell you what the best option for you is. If you do decide to use our services, then know that our fees are very reasonable. However, you need to act fast as there may be time-barring restrictions in place.

Call us now for a phone or video consultation with one of our legal experts on 0800 041 8358 to find out if you are entitled to compensation, you may even be entitled to additional compensation if you have successfully claimed in the past.

NB: Information for this page was gathered on 18/11/2024 from the following sources, FSCS Website, FCA Register, Companies House Register and is to our knowledge accurate as of that date.

Company background (public record)

The company was incorporated at Companies House on 20 July 2018 under company number SE000118. Its status at Companies House is recorded as closed.

Registered office: 7th Floor 52-56 Leadenhall Street, London, EC3A 2BJ, United Kingdom.

Nature of business (SIC): 66220.

Company timeline (public record)

Key dated events for this firm, drawn from public records. Each entry shows its source.

Date Event Source
29 Nov 2006 David Thomas Betteley approved by the FCA at the firm FCA Register
29 Nov 2006 Michael Rainer Kainzbauer approved by the FCA at the firm FCA Register
29 Nov 2006 Gerald Philip Rushe approved by the FCA at the firm FCA Register
29 Nov 2006 Walter Leyendecker approved by the FCA at the firm FCA Register
29 Nov 2006 Jean-Pierre Georges Marie Nicolas Valson approved by the FCA at the firm FCA Register
29 Nov 2006 Masanobu Kobayashi approved by the FCA at the firm FCA Register
29 Nov 2006 Christian Wolfgang Alt approved by the FCA at the firm FCA Register
29 Nov 2006 Yoshihiko Endo approved by the FCA at the firm FCA Register
29 Nov 2006 Gregor Stimpfl approved by the FCA at the firm FCA Register
29 Sep 2008 Michael Swanborough approved by the FCA at the firm FCA Register
24 Dec 2008 Maria Luisa Saenz Cobeno approved by the FCA at the firm FCA Register
19 May 2009 Peter Pollhammer approved by the FCA at the firm FCA Register
18 Jun 2010 Yoshihiko Fukasawa approved by the FCA at the firm FCA Register
25 Feb 2011 Touri Ueno approved by the FCA at the firm FCA Register
14 Mar 2011 Ivo Ljubica approved by the FCA at the firm FCA Register
02 Aug 2011 TOYOTA(G.B.) PLC. appointed as appointed representative FCA Register
30 Oct 2012 Miguel Silva Ramalho Fonseca approved by the FCA at the firm FCA Register
23 Oct 2015 Douglas Frank Gillies approved by the FCA at the firm FCA Register
10 May 2016 Kohji Ohnishi approved by the FCA at the firm FCA Register
20 Jul 2018 Company incorporated Companies House
20 Jul 2018 Douglas Frank Gillies appointed member-of-an-administrative-organ Companies House
20 Jul 2018 Michael Rainer Kainzbauer appointed member-of-an-administrative-organ Companies House
20 Jul 2018 Masato Kume appointed member-of-an-administrative-organ Companies House
20 Jul 2018 Ivo-Josko Ljubica appointed member-of-an-administrative-organ Companies House
20 Jul 2018 Kohji Ohnishi appointed member-of-an-administrative-organ Companies House
20 Jul 2018 Michael John Swanborough appointed member-of-an-administrative-organ Companies House
19 Mar 2019 FCA status recorded as: No longer authorised FCA Register
19 Mar 2019 TOYOTA(G.B.) PLC. ceased as appointed representative FCA Register

Focused on the firm’s early history and the events leading up to and following its failure. 2 routine entries from its active years are omitted.

Who was involved?

The following individuals are listed on public records in connection with the firm. These are matters of public record only and their inclusion does not imply any wrongdoing by any named person.

  • David Thomas Betteley. Listed on the FCA Register as having held CF1 Director (29/11/2006 to 09/10/2009) at the firm.
  • Michael Rainer Kainzbauer. Listed on the FCA Register as having held Responsible for Insurance Distribution (01/10/2018 to 19/03/2019), CF3 Chief Executive (29/11/2006 to 19/03/2019), CF1 Director (29/11/2006 to 19/03/2019), Responsible for Insurance Mediation (08/03/2012 to 30/09/2018) at the firm.
  • Douglas Frank Gillies. Listed on the FCA Register as having held CF2 Non Executive Director (23/10/2015 to 19/03/2019) at the firm.
  • Kohji Ohnishi. Listed on the FCA Register as having held CF2 Non Executive Director (10/05/2016 to 19/03/2019) at the firm.
  • Michael Swanborough. Listed on the FCA Register as having held CF2 Non Executive Director (29/09/2008 to 19/03/2019) at the firm.
  • Gerald Philip Rushe. Listed on the FCA Register as having held Responsible for Insurance Mediation (29/11/2006 to 31/03/2008), CF8 Apportionment and Oversight (29/11/2006 to 31/03/2008), CF3 Chief Executive (29/11/2006 to 31/03/2008), CF1 Director (29/11/2006 to 31/03/2008) at the firm.
  • Francois Radot. Listed on the FCA Register as having held CF1 Director (01/09/2010 to 01/01/2012) at the firm.
  • Peter Pollhammer. Listed on the FCA Register as having held CF2 Non Executive Director (19/05/2009 to 01/10/2012) at the firm.
  • Touri Ueno. Listed on the FCA Register as having held CF2 Non Executive Director (25/02/2011 to 31/12/2012) at the firm.
  • Walter Leyendecker. Listed on the FCA Register as having held CF2 Non Executive Director (29/11/2006 to 01/01/2009) at the firm.

Appointed Representatives and Agents

While it was authorised, the firm acted as principal for the following appointed representatives. An appointed representative carries on regulated business under the responsibility of its principal, so their conduct can be relevant to a claim.

Appointed representative Reference Effective from Ended
TOYOTA(G.B.) PLC. FRN 402555 02/08/2011 19/03/2019


Review page sources: FCA Register (FRN 454020) · Companies House (SE000118). Public records, provided for transparency.

When it comes to Claims,
we won’t waste your time or ours.

This is why we have a 82%* success rate on submitted claims in similar circumstances to MedDen Financial Services LLP

*82% success rate is an accurate figure based on pension and investment related claims submitted and concluded between 1st December 2020 to 1st August 2024.

Latest FSCS Update

Our team is currently working to obtain the latest update on this company. Please check back later for further information.

If you believe you may have been affected, please book a free consultation with our team. We will carry out all the investigative work on your behalf. If your claim is not successful, you will not pay a penny. You can call us during office hours or email hello@claimmyloss.co.uk – we are here to help.

Our Process for Making a Mis-sold Claim

Initial Consultation

Start a free consultation to understand your situation and help you decide on the best course of action.

Collect & Review Agreements

We”ll collect and review your documentation of the advice given, pension transfer details, and evidence of any financial losses.

Submit a Claim

We will formally submit your claim to the relevant parties, clearly outlining why you’re entitled to compensation.

How much is your financial adviser claim worth?

Use our Claim Calculator 

Related News

Are you worried you could be worse off due to dealing with MedDen Financial Services LLP?

Request a call back

Layer 6

We’ve successfully helped 1000's of people get the compensation they deserve.

Find out if you’re eligible…

investigation

1 Jul 2026

FSCS completes part of its Equity For Growth investigation – what investors need to know

Saad Ashraf

wealthtek update

29 Jun 2026

WealthTek update: CACEIS UK censured and to pay £31.7m for the benefit of clients

Saad Ashraf

Green wealth management

9 Jun 2026

Green Wealth Management: why these claims are upheld, and what they could be worth

Saad Ashraf